Accellent Inc. Announces Certain Preliminary Fourth Qu
and Full Year 2009 Financial Information
January 19, 2010 05:33 AM Eastern Time
WILMINGTON, Mass.--(EON: Enhanced Online News)--Accellent Inc. (the “Company”), a wholly owned subsidiary of Accelle
(“Accellent”), today announced certain preliminary financial information for its fiscal fourth quarter and the full year ended Decembe
information remains preliminary and subject to audit.
The Company expects net sales for the fiscal fourth quarter to total approximately $109.0 million to $111.0 million and expects net
year ended December 31, 2009 to total approximately $477.0 million to $479.0 million. In addition, the Company expects that, as
2009, it remained in compliance with the leverage ratio and coverage ratio covenants set forth in its existing credit facility, with such
to those as of September 30, 2009.
Accellent provides fully integrated outsourced manufacturing and engineering services to the medical device industry in the cardiolog
drug delivery, neurology and orthopaedic markets. Accellent has broad capabilities in design and engineering services, precision co
fabrication, finished device assembly and complete supply chain management. These capabilities enhance customers’ speed to mark
investment by allowing them to refocus internal resources more efficiently. For more information, please visit www.accellent.com.
This press release includes “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amen
21E of the Securities Act of 1934, as amended. All statements included herein, other than statements of historical fact, may constitut
statements. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it ca
assurance that such expectations will prove to be correct. Important factors that could cause actual results to differ materially from t
expectations are disclosed in the risk factors cont